Bo Kruse

Director of Finance/CFO at Y-MABS THERAPEUTICS, INC.

Net worth: 3 M $ as of 31/03/2024

52 year

Health Technology

Consumer Services

Commercial Services

Bo Kruse active positions

Companies	Position	Start	End
Y-MABS THERAPEUTICS, INC.	Corporate Secretary	01/06/2015	-
	Director of Finance/CFO	01/06/2015	-
	Treasurer	01/06/2015	-
	Director/Board Member	01/06/2015	06/06/2019

Companies	Position	Start	End
Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	Director of Finance/CFO	30/07/2010	01/01/2015
GENMAB A/S	Comptroller/Controller/Auditor	01/01/2000	01/01/2005
GENMAB A/S	Director of Finance/CFO	01/01/2005	02/06/2008
PricewaterhouseCoopers (Denmark) PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark.	Corporate Officer/Principal	-	-

Copenhagen Business School

Graduate Degree

International

Denmark	5
	2

Operational

Director of Finance/CFO	3
Comptroller/Controller/Auditor	1
Graduate Degree	1

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
GENMAB A/S	Health Technology

Private companies	3
PricewaterhouseCoopers (Denmark) PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark.	Commercial Services
Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	Health Technology
Y-mAbs Therapeutics, Inc.